Ignite Creation Date:
2025-12-26 @ 2:40 PM
Ignite Modification Date:
2026-01-20 @ 3:04 PM
Study NCT ID:
NCT02334306
Status:
COMPLETED
Last Update Posted:
2019-03-19
First Post:
2014-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-13
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-12
First Submit QC Date:
None
Study First Post Date:
2015-01-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-01-16
Results First Submit QC Date:
None
Results First Post Date:
2019-03-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-27
Last Update Post Date:
2019-03-19
Last Update Post Date Type:
ACTUAL